106 related articles for article (PubMed ID: 11765615)
1. [Dopamine receptor gene (DRD2) polymorphism in patients with endogenous psychoses with regard to their clinical heterogeneity].
Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Brusentseva LN; Nosikov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):50-3. PubMed ID: 11765615
[TBL] [Abstract][Full Text] [Related]
2. [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].
Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Braga EA; Nosikov VV; Trubnikov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(12):32-5. PubMed ID: 9866157
[TBL] [Abstract][Full Text] [Related]
3. Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.
Kwon JS; Kim E; Kang DH; Choi JS; Yu KS; Jang IJ; Shin SG;
Eur Neuropsychopharmacol; 2008 Dec; 18(12):897-907. PubMed ID: 18786813
[TBL] [Abstract][Full Text] [Related]
4. [Serotonin receptor gene allele polymorphism (5HTR2A) and clinical pathogenetic characteristics in patients with schizophrenia and schizophrenia spectrum disorders].
Golimbet VE; Manandian KK; Abramova LI; Orlova VA; Kaleda VG; Oleĭchik IV; Iurov IuB; Trubnikov VI
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(2):36-9. PubMed ID: 10709289
[TBL] [Abstract][Full Text] [Related]
5. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls.
Weiss J; Mägert HJ; Cieslak A; Forssmann WG
Eur J Med Res; 1996 Jun; 1(9):439-45. PubMed ID: 9353244
[TBL] [Abstract][Full Text] [Related]
6. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.
Lee HS; Kim SH; Lee HJ; Kim L; Lee SK; Jang DW; Lee MS; Son BG; Suh KY; Kim S
Am J Med Genet; 2002 Aug; 114(6):593-7. PubMed ID: 12210271
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor Taq IA polymorphism is associated with postoperative nausea and vomiting.
Nakagawa M; Kuri M; Kambara N; Tanigami H; Tanaka H; Kishi Y; Hamajima N
J Anesth; 2008; 22(4):397-403. PubMed ID: 19011779
[TBL] [Abstract][Full Text] [Related]
9. Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
Miura I; Zhang JP; Hagi K; Lencz T; Kane JM; Yabe H; Malhotra AK; Correll CU
Psychoneuroendocrinology; 2016 Oct; 72():1-10. PubMed ID: 27333159
[TBL] [Abstract][Full Text] [Related]
10. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review.
Noble EP
Eur Psychiatry; 2000 Mar; 15(2):79-89. PubMed ID: 10881203
[TBL] [Abstract][Full Text] [Related]
11. [Dopamine receptor DRD4 gene polymorphism and its association with schizophrenia spectrum disorders and personality traits of patients].
Golimbet VE; Gritsenko IK; Alfimova MV; Lezheĭko TV; Abramova LI; Barkhatova AN; Kasparov SV; Ebshteĭn RP
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(9):42-7. PubMed ID: 16252386
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
13. [Linkage sib-pair analysis of dopamine receptor D2 gene Taq1A and Taq1B polymorphism and schizophrenia].
Golimbet VE; Aksenova MG; Nosikov VV; Orlova VA; Kaleda VG
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(4):43-4. PubMed ID: 12001666
[No Abstract] [Full Text] [Related]
14. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
Rybakowski JK; Borkowska A; Czerski PM; Hauser J
Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801
[TBL] [Abstract][Full Text] [Related]
15. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population.
Ambrósio AM; Kennedy JL; Macciardi F; Macedo A; Valente J; Dourado A; Oliveira CR; Pato C
Psychiatry Res; 2004 Mar; 125(3):185-91. PubMed ID: 15051179
[TBL] [Abstract][Full Text] [Related]
16. [Insertion-deletion polymorphism of angiotensin-1-converting enzyme gene in patients with endogenic psychoses].
Golimbet VE; Andreev TV; Abramova LI; Kaleda VG
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):70-3. PubMed ID: 15704489
[TBL] [Abstract][Full Text] [Related]
17. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients.
Hoenicka J; Aragüés M; Rodríguez-Jiménez R; Ponce G; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T;
Acta Psychiatr Scand; 2006 Dec; 114(6):435-8. PubMed ID: 17087792
[TBL] [Abstract][Full Text] [Related]
18. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.
Lawford BR; Young RM; Swagell CD; Barnes M; Burton SC; Ward WK; Heslop KR; Shadforth S; van Daal A; Morris CP
Schizophr Res; 2005 Feb; 73(1):31-7. PubMed ID: 15567074
[TBL] [Abstract][Full Text] [Related]
19. The mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early Psychosis.
Cui Y; Prabhu V; Nguyen TB; Yadav BK; Chung YC
Int J Mol Sci; 2015 Nov; 16(11):26677-86. PubMed ID: 26561806
[TBL] [Abstract][Full Text] [Related]
20. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population.
Staddon S; Arranz MJ; Mancama D; Perez-Nievas F; Arrizabalaga I; Anney R; Buckland P; Elkin A; Osborne S; Munro J; Mata I; Kerwin RW
Schizophr Res; 2005 Feb; 73(1):49-54. PubMed ID: 15567076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
